Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies
Allogenic hematopoietic cell transplantation (HSCT) is typically the preferred curative therapy for adult patients with acute myeloid leukemia, but its use has been reduced as a consequence of limited donor availability in the form of either matched-related donors (MRD) or matched-unrelated donors (...
Main Authors: | William A. Fabricius, Muthalagu Ramanathan |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2016/5726132 |
Similar Items
-
Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies
by: Elisa Zaghi, et al.
Published: (2019-11-01) -
Review of Haploidentical Hematopoietic Cell Transplantation
by: Mehreen A. Khan, et al.
Published: (2018-12-01) -
Haploidentical Hematopoietic Stem Cell Transplantation: Expanding the Horizon for Hematologic Disorders
by: Mohammad Faizan Zahid, et al.
Published: (2016-01-01) -
Haploidentical Hematopoietic Stem Cell Transplantation Versus Umbilical Cord Blood Transplantation in Hematologic Malignancies: A Systematic Review and Meta-Analysis
by: Ran Wu, et al.
Published: (2020-10-01) -
Haploidentical stem cell transplants with Post transplantation cyclophosphamide for Hematological malignancies in children
by: Neha Rastogi, et al.
Published: (2016-01-01)